3 October 2023

Last updated: Monday 2 October 2023

Research Directory

New opportunities for small molecules in cancer

Development timelines for new oncology drugs

Swiss companies weather the turmoil in 2022

Capturing the promise of p38 MAPK inhibition

Destiny Pharma advances strategy against bacteria

HIV vaccine remains elusive but antivirals deliver value

FDA guides on accelerated approvals in oncology

Stock values decline and companies restructure

Adrenomed prepares global study in septic shock

Oncology pipeline marked by multiple therapy types